V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16627397 | 330006962 | EE813 | 140 | X729 | 1 | 2013-07-12 | CYCLOPHOSPHAMIDE | 330006053 | 330003738 | 330006964 |
| 16627398 | 330006962 | EK1PP | 190 | X721 | 1 | 2013-07-13 | DOXORUBICIN | 330006053 | 330003738 | 330006964 |
| 16627399 | 330006963 | EGQ01 | 814.5 | X724 | 1 | 2014-03-07 | RITUXIMAB | 330006058 | 330003742 | 330006965 |
| 16627409 | 330006967 | EE813 | 814.5 | X724 | 1 | 2014-01-30 | THIOTEPA | 330006497 | 330003746 | 330006969 |
| 16627410 | 330006967 | EZ102 | null | X722 | 1 | 2014-01-30 | IFOSFAMIDE | 330006497 | 330003746 | 330006969 |
| 16627411 | 330006968 | ED301 | 2040 | null | 1 | 2013-12-10 | CYTARABINE | 330006633 | 330003748 | 330006970 |
| 16627412 | 330006968 | EK1EN | 193 | X728 | 1 | 2013-12-10 | ETOPOSIDE | 330006633 | 330003748 | 330006970 |
| 16627413 | 330006968 | E1UZ0 | 150 | X724 | 5 | 2013-12-10 | IFOSFAMIDE | 330006633 | 330003748 | 330006970 |
| 16627414 | 330006973 | EE813 | 100 | X724 | 1 | 2017-10-14 | NOT MATCHED | 330007179 | 330012763 | 330006975 |
| 16627415 | 330006973 | EEI00 | 16 | X729 | 1 | 2017-10-14 | IFOSFAMIDE | 330007179 | 330012763 | 330006975 |
| 16627416 | 330006973 | EEI00 | 8 | X728 | 1 | 2017-10-16 | DACTINOMYCIN | 330007179 | 330012763 | 330006975 |
| 16627417 | 330006973 | EPH | 1.6 | null | 1 | 2017-10-17 | CYTARABINE | 330007179 | 330012763 | 330006975 |
| 16627418 | 330006973 | EEI00 | 0 | X721 | 1 | 2017-10-17 | MESNA | 330007179 | 330012763 | 330006975 |
| 16627419 | 330006973 | EOF | 40 | null | 1 | 2017-10-17 | IFOSFAMIDE | 330007179 | 330012763 | 330006975 |
| 16627420 | 330006973 | EW100 | 145 | X724 | 1 | 2017-10-17 | CISPLATIN | 330007179 | 330012763 | 330006975 |
| 16627421 | 330006973 | Haqrsvarq | 1 | X721 | 2 | 2017-10-17 | NOT CHEMO | 330007179 | 330012763 | 330006975 |
| 16627422 | 330006975 | Haqrsvarq | 100 | X721 | 1 | 2013-05-02 | DAUNORUBICIN | 330007189 | 330003753 | 330006977 |
| 16627423 | 330006976 | EEI00 | 814.5 | x724 | 1 | 2016-12-29 | CYTARABINE | 330007202 | 330010353 | 330006978 |
| 16627424 | 330006976 | ETG | null | null | 1 | 2017-01-02 | ETOPOSIDE | 330007202 | 330010353 | 330006978 |
| 16627425 | 330006976 | EEI00 | 5600 | null | 1 | 2017-01-03 | CISPLATIN | 330007202 | 330010353 | 330006978 |
| 16627426 | 330006977 | EEI00 | 2750 | X724 | 2 | 2014-02-04 | NIVOLUMAB | 330007202 | 330010353 | 330006979 |
| 16627427 | 330006978 | EE813 | 700 | null | 1 | 2016-05-07 | CETUXIMAB | 330007202 | 330010353 | 330006980 |
| 16627428 | 330006978 | EUZ | 3600 | X729 | 1 | 2016-05-08 | CYCLOPHOSPHAMIDE | 330007202 | 330010353 | 330006980 |
| 16627429 | 330006978 | ETG | 150 | null | 9 | 2016-05-08 | NOT CHEMO | 330007202 | 330010353 | 330006980 |
| 16627430 | 330006979 | EGU08 | 1800 | X721 | 1 | 2016-07-21 | CISPLATIN | 330007202 | 330010353 | 330006981 |
| 16627431 | 330006979 | ERA20 | 76 | X729 | 1 | 2016-07-22 | IFOSFAMIDE | 330007202 | 330010353 | 330006981 |
| 16627432 | 330006979 | ECL02 | 5400 | null | 2 | 2016-07-22 | NOT CHEMO | 330007202 | 330010353 | 330006981 |
| 16627433 | 330006979 | EEI00 | 50 | X724 | 2 | 2016-07-22 | MULTIPLE | 330007202 | 330010353 | 330006981 |
| 16627434 | 330006979 | EEI00 | 0 | X721 | 1 | 2016-07-22 | IFOSFAMIDE | 330007202 | 330010353 | 330006981 |
| 16627435 | 330006979 | EJU04 | 1400 | X721 | 1 | 2016-07-23 | FLUOROURACIL | 330007202 | 330010353 | 330006981 |
| 16627436 | 330006979 | EGENG | 1000 | null | 1 | 2016-07-23 | FLUOROURACIL | 330007202 | 330010353 | 330006981 |
| 16627437 | 330006979 | EWR01 | 1 | null | 1 | 2016-07-24 | NOT CHEMO | 330007202 | 330010353 | 330006981 |
| 16627438 | 330006979 | EKY01 | 3600 | X724 | 1 | 2016-07-25 | FLUOROURACIL | 330007202 | 330010353 | 330006981 |
| 16627439 | 330006979 | ED8Y0 | 8 | X721 | 2 | 2016-07-25 | STEROID | 330007202 | 330010353 | 330006981 |
| 16627440 | 330006984 | ECL01 | 3800 | X724 | 1 | 2018-03-15 | ETOPOSIDE | 330007231 | 330003763 | 330006986 |
| 16627441 | 330006984 | ETG01 | 4560 | null | 1 | 2018-03-16 | CYCLOPHOSPHAMIDE | 330007231 | 330003763 | 330006986 |
| 16627442 | 330006984 | EGU02 | 100 | X724 | null | 2018-04-05 | CETUXIMAB | 330007231 | 330003763 | 330006986 |
| 16627443 | 330006984 | ECL02 | 360 | X724 | 1 | 2018-04-05 | CYTARABINE | 330007231 | 330003763 | 330006986 |
| 16627444 | 330006985 | EEI00 | 20 | X724 | 1 | 2016-09-21 | NIVOLUMAB | 330007231 | 330003763 | 330006987 |
| 16627445 | 330006985 | EEI00 | 3200 | X731 | null | 2016-09-23 | NOT CHEMO | 330007231 | 330003763 | 330006987 |
| 16627446 | 330006985 | ETG | null | X724 | 1 | 2016-09-30 | CETUXIMAB | 330007231 | 330003763 | 330006987 |
| 16627447 | 330006986 | EEI00 | 240 | X728 | 1 | null | CYTARABINE | 330007231 | 330003763 | 330006988 |
| 16627448 | 330006986 | ERA20 | 100 | null | 1 | null | TOPOTECAN | 330007231 | 330003763 | 330006988 |
| 16627449 | 330006986 | EEI00 | 100 | X729 | 1 | null | ETOPOSIDE | 330007231 | 330003763 | 330006988 |
| 16627450 | 330006988 | EE813 | 60 | X721 | 1 | 2015-09-03 | NOT MATCHED | 330007251 | 330003770 | 330006990 |
| 16627451 | 330006988 | ERA20 | 815 | X731 | 1 | 2015-09-04 | METHOTREXATE | 330007251 | 330003770 | 330006990 |
| 16627452 | 330006988 | EGQ01 | 20 | null | 1 | 2015-09-04 | ETOPOSIDE | 330007251 | 330003770 | 330006990 |
| 16627453 | 330006988 | ETG | 85 | null | 2 | 2015-09-05 | CYCLOPHOSPHAMIDE | 330007251 | 330003770 | 330006990 |
| 16627454 | 330006988 | EK1PP | 1.7 | X721 | null | 2015-09-05 | NOT CHEMO | 330007251 | 330003770 | 330006990 |
| 16627455 | 330006988 | Haqrsvarq | 0 | X724 | 2 | 2015-09-05 | NOT CHEMO | 330007251 | 330003770 | 330006990 |